ATE328594T1 - Verwendung von dipeptidyl peptidase iv inhibitoren zur verbesserung der fruchtbarkeit - Google Patents

Verwendung von dipeptidyl peptidase iv inhibitoren zur verbesserung der fruchtbarkeit

Info

Publication number
ATE328594T1
ATE328594T1 AT00911186T AT00911186T ATE328594T1 AT E328594 T1 ATE328594 T1 AT E328594T1 AT 00911186 T AT00911186 T AT 00911186T AT 00911186 T AT00911186 T AT 00911186T AT E328594 T1 ATE328594 T1 AT E328594T1
Authority
AT
Austria
Prior art keywords
inhibitors
dipeptidyl peptidase
improve fertility
fertility
improve
Prior art date
Application number
AT00911186T
Other languages
English (en)
Inventor
Pierre Broqua
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of ATE328594T1 publication Critical patent/ATE328594T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT00911186T 1999-03-23 2000-03-21 Verwendung von dipeptidyl peptidase iv inhibitoren zur verbesserung der fruchtbarkeit ATE328594T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9906714.2A GB9906714D0 (en) 1999-03-23 1999-03-23 Compositions for improving fertility

Publications (1)

Publication Number Publication Date
ATE328594T1 true ATE328594T1 (de) 2006-06-15

Family

ID=10850229

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911186T ATE328594T1 (de) 1999-03-23 2000-03-21 Verwendung von dipeptidyl peptidase iv inhibitoren zur verbesserung der fruchtbarkeit

Country Status (29)

Country Link
US (1) US7115650B1 (de)
EP (1) EP1162969B1 (de)
JP (1) JP2002539243A (de)
KR (1) KR100689951B1 (de)
CN (1) CN1196483C (de)
AR (1) AR023129A1 (de)
AT (1) ATE328594T1 (de)
AU (1) AU765912B2 (de)
CA (1) CA2366911C (de)
CZ (1) CZ20013410A3 (de)
DE (1) DE60028552T2 (de)
DK (1) DK1162969T3 (de)
ES (1) ES2265918T3 (de)
GB (1) GB9906714D0 (de)
HK (1) HK1046647B (de)
HU (1) HUP0200410A3 (de)
IL (1) IL145569A0 (de)
MX (1) MXPA01009612A (de)
MY (1) MY135683A (de)
NO (1) NO20014607L (de)
NZ (1) NZ514449A (de)
PL (1) PL195779B1 (de)
PT (1) PT1162969E (de)
RU (1) RU2246944C2 (de)
TR (1) TR200102647T2 (de)
TW (1) TWI244920B (de)
UA (1) UA77644C2 (de)
WO (1) WO2000056296A2 (de)
ZA (1) ZA200108083B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
GB9928330D0 (en) 1999-11-30 2000-01-26 Ferring Bv Novel antidiabetic agents
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
WO2002072582A1 (en) 2001-03-12 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine template libraries
GB0109146D0 (en) * 2001-04-11 2001-05-30 Ferring Bv Treatment of type 2 diabetes
NZ529973A (en) 2001-06-27 2006-01-27 Smithkline Beecham Corp Fluoropyrrolidines as dipeptidyl peptidase inhibitors
EP1399433B1 (de) 2001-06-27 2007-08-22 Smithkline Beecham Corporation Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
JP4300108B2 (ja) 2001-06-27 2009-07-22 スミスクライン ビーチャム コーポレーション ジペプチジルペプチダーゼ阻害剤としてのピロリジン類
DE60304911D1 (de) 2002-02-25 2006-06-08 Eisai Co Ltd Xanthin-Derivate als DPP-IV-Inhibitoren
US6710040B1 (en) 2002-06-04 2004-03-23 Pfizer Inc. Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
EP1514552A4 (de) 2002-06-06 2008-04-02 Eisai R&D Man Co Ltd Neues kondensiertes imidazolderivativ
WO2005026114A1 (en) * 2003-09-17 2005-03-24 Pfizer Inc. Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
SI1942898T2 (sl) 2005-09-14 2014-08-29 Takeda Pharmaceutical Company Limited Dipeptidil-peptidazni inhibitorji za zdravljenje diabetesa
CN102675221A (zh) 2005-09-16 2012-09-19 武田药品工业株式会社 用于制备嘧啶二酮衍生物的方法中的中间体
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia
EP2108960A1 (de) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Verfahren zur Verwendung eines A G Protein-gekoppelten Rezeptors zur Identifikation von Peptid YY (PYY) Sekretagoga und nützliche Verbindungen zur Behandlung von durch (PYY) Sekretagoga modulierten Zuständen und nützliche Verbindungen zur Behandlung von Zuständen durch PYY
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
EP2556056A1 (de) 2010-04-06 2013-02-13 Arena Pharmaceuticals, Inc. Modulatoren des gpr119-rezeptors und behandlung von damit assoziierten erkrankungen
WO2012040279A1 (en) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140066369A1 (en) 2011-04-19 2014-03-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
JP2018507914A (ja) 2015-03-09 2018-03-22 インテクリン・セラピューティクス・インコーポレイテッド 非アルコール性脂肪肝疾患および／またはリポジストロフィーの処置のための方法
US11096924B2 (en) * 2016-09-07 2021-08-24 Trustees Of Tufts College Combination therapies using immuno-dash inhibitors and PGE2 antagonists
BR112019020485A2 (pt) 2017-04-03 2020-05-12 Coherus Biosciences, Inc. Agonista ppary para tratamento de paralisia supranuclear progressiva

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2080474A1 (en) 1990-04-14 1991-10-15 William W. Bachovchin Inhibitors of dipeptidyl-aminopeptidase type iv
ATE199016T1 (de) * 1991-10-22 2001-02-15 New England Medical Center Inc Inhibitoren der dipeptidyl-aminopeptidase vom typ-iv
IL111785A0 (en) 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US5952301A (en) 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function

Also Published As

Publication number Publication date
PL350797A1 (en) 2003-02-10
HUP0200410A3 (en) 2002-09-30
AU765912B2 (en) 2003-10-02
CA2366911A1 (en) 2000-09-28
HK1046647A1 (en) 2003-01-24
PL195779B1 (pl) 2007-10-31
NZ514449A (en) 2002-11-26
DK1162969T3 (da) 2006-09-18
HUP0200410A2 (en) 2002-08-28
DE60028552T2 (de) 2007-06-28
CN1352557A (zh) 2002-06-05
CN1196483C (zh) 2005-04-13
CA2366911C (en) 2010-01-19
US7115650B1 (en) 2006-10-03
ES2265918T3 (es) 2007-03-01
EP1162969B1 (de) 2006-06-07
GB9906714D0 (en) 1999-05-19
KR100689951B1 (ko) 2007-03-08
WO2000056296A3 (en) 2001-01-25
DE60028552D1 (de) 2006-07-20
RU2246944C2 (ru) 2005-02-27
TR200102647T2 (tr) 2002-01-21
AR023129A1 (es) 2002-09-04
EP1162969A2 (de) 2001-12-19
NO20014607L (no) 2001-11-20
JP2002539243A (ja) 2002-11-19
NO20014607D0 (no) 2001-09-21
TWI244920B (en) 2005-12-11
ZA200108083B (en) 2002-11-27
CZ20013410A3 (cs) 2002-04-17
PT1162969E (pt) 2006-10-31
WO2000056296A2 (en) 2000-09-28
UA77644C2 (en) 2007-01-15
MY135683A (en) 2008-06-30
IL145569A0 (en) 2002-06-30
MXPA01009612A (es) 2002-07-02
HK1046647B (zh) 2005-09-30
AU3317700A (en) 2000-10-09
KR20010108388A (ko) 2001-12-07

Similar Documents

Publication Publication Date Title
DE60028552D1 (de) Verwendung von dipeptidyl peptidase IV Inhibitoren zur Verbesserung der Fruchtbarkeit
NO20006483L (no) Forbindelser av ustabile dipeptidyl peptidase IV-inhibitorer
MA28578B1 (fr) Dérivés de proline et leur utilisation comme inhibiteurs de la dipeptidyl-peptidase IV
GB0010183D0 (en) Inhibitors of dipeptidyl peptidase IV
DE60102137D1 (de) Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren
NO20024295D0 (no) Cyclopropyl-kondenserte pyrrolidin-baserte inhibitorer av dipeptidyl peptidase IV og fremgangsmåte
EP1465891A4 (de) Inhibitoren von dipeptidylpeptidase iv
PL370220A1 (en) Inhibitors of dipeptidyl peptidase iv
ATE380175T1 (de) Pyrrolidine als dipeptidyl peptidase inhibitoren
NZ514450A (en) Use of dipeptidyl peptidase IV inhibitors for promoting growth
ATE370943T1 (de) Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
DE59910084D1 (de) Organische Salze von Isoleucyl-Thiazolidin und -Pyrrolidin und ihre Verwendung als Dipeptidylpeptidase-Inhibitoren
ATE387444T1 (de) Substituierte pyrroline als kinase inhibitoren
AU2003286776A1 (en) Novel inhibitors of dipeptidyl peptidase iv
DE60239629D1 (de) N-substituirte pyrrolidin derivate als dipeptidyl peptidase inhibitoren
PL377123A1 (pl) Sposoby i związki do wytwarzania inhibitorów peptydazy dipeptydylowej IV i ich związków pośrednich
DE60110232D1 (de) Neue verwendung von lipase-inhibitoren
ATE447553T1 (de) Piperidinverbindungen zur verwendung als ccr-3- inhibitoren
EE200100514A (et) LFA-1 ICAM-idega seondumise inhibiitorid ja nendekasutamine
EE200100371A (et) Amidinobensüülamiini derivaadid ja nende kasutamine trombiini inhibiitoritena
EE03745B1 (et) Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena
ATE302781T1 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
IL138601A0 (en) Pyrrolidines as inhibitors of neuraminidases
DE1206274T1 (de) Verwendung von interleukin-18-inhibitoren zur hemmung von tumormetastasierung
DE69834262D1 (de) Neue pharnazeutische verwendung von c-c chemokin produktionsinhibitoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1162969

Country of ref document: EP

REN Ceased due to non-payment of the annual fee